Conquering combined thoracic organ and liver transplantation: Indications and outcomes for heart-liver and lung-liver transplantation Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Hepatocellular
  • Liver Neoplasms
  • Liver Transplantation
  • Neoplasm Recurrence, Local

abstract

  • Combined thoracic and liver transplant continues to be a viable treatment option for patients with end-stage disease that would likely not survive single transplant alone. Salvage modalities, such as extracorporeal membrane oxygenation and ex-vivo lung perfusion, may help in extending candidacy for this combined transplant. Outcomes, to date, are similar to results observed for solitary thoracic organ recipients, justifying CHLT and CLLT as a viable option for these patients. Continued identification of outcomes is needed to justify allocation of dual organs to a single recipient.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/MOT.0000000000000509

PubMed ID

  • 29389820

Additional Document Info

start page

  • 180

end page

  • 186

volume

  • 23

number

  • 2